EDWARD GRAHAM: Open Payments
NPI 1417525361 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 22 payments from 6 companies in 2025. Trend: 2023 $584 · 2024 $356 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $250 |
| E.R. Squibb & Sons, L.L.C. | 2 | $146 |
| Otsuka America Pharmaceutical, Inc. | 2 | $143 |
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Lundbeck LLC | 1 | $24 |
| Alkermes, Inc. | 1 | $22 |
Products named: VRAYLAR, COBENFY, REXULTI, INGREZZA, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across NV — which companies pay providers there.
